FDA OKs Lumateperone (Caplyta) for Prevention of Schizophrenia Relapse - Medscape

Submitted by Anonymous (not verified) on Tue, 04/28/2026 - 13:47

FDA OKs Lumateperone (Caplyta) for Prevention of Schizophrenia Relapse  Medscape